Back to Journals » Journal of Inflammation Research » Volume 15

Gamma Radiation Induce Inflammasome Signaling and Pyroptosis in Microvascular Endothelial Cells [Corrigendum]

Authors Smith AO, Ju W, Adzraku SY, wenyi L, Yuting C, Qiao J, Xu K , Zeng L

Received 15 March 2022

Accepted for publication 15 March 2022

Published 24 March 2022 Volume 2022:15 Pages 1991—1992

DOI https://doi.org/10.2147/JIR.S366527



Smith AO, Ju W, Adzraku SY, et al. J Inflamm Res. 2021;14:3277–3288

Following a review of the paper post-publication, the authors realized they had mistakenly duplicated the immunofluorescence on Figure 6 during the figure preparation.

On page 3286, the corrected Figure 6 is shown in Download Article:

Figure 6 Gamma radiation directly activates Caspase-1 dependent pathway in microvascular endothelial cells.

Abbreviation: NS, not significant.

Notes: (A) Immunofluorescence images of cleaved caspase −1 in microvascular endothelial cells. (B) The mean fluorescence intensity of cleaved caspase −1 in microvascular endothelial cells in the graph was relatively quantified by image J, which shows a dose-dependent increase in the expression of cleaved caspase-1. The results were representative of 6 independent experiments of four repeats (N=4) (mean ± SD) *P<0.05, ****P

The authors affirm that this error does not affect the results, discussion, and conclusions of the reported study and apologize for any inconvenience caused to the readers.

Read the original article

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.